These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 21813338)

  • 1. Emerging therapies for advanced gastroenteropancreatic neuroendocrine tumors.
    Gupta S; Engstrom PF; Cohen SJ
    Clin Colorectal Cancer; 2011 Dec; 10(4):298-309. PubMed ID: 21813338
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gastroenteropancreatic neuroendocrine tumors: update on therapeutics.
    Ganetsky A; Bhatt V
    Ann Pharmacother; 2012 Jun; 46(6):851-62. PubMed ID: 22589450
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [New therapeutic strategies in gastroenteropancreatic neuroendocrine tumours].
    Colao A; Pulcrano M; Dorato M; Müller F; Rossi FW; De Martino MC; Biondi B; Lombardi G
    Minerva Endocrinol; 2001 Dec; 26(4):231-8. PubMed ID: 11782708
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel therapeutic agents for the treatment of gastroenteropancreatic neuroendocrine tumors.
    Pavel ME; Wiedenmann B
    Horm Metab Res; 2011 Nov; 43(12):844-53. PubMed ID: 22105475
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel anticancer agents in clinical trials for well-differentiated neuroendocrine tumors.
    Faivre S; Sablin MP; Dreyer C; Raymond E
    Endocrinol Metab Clin North Am; 2010 Dec; 39(4):811-26. PubMed ID: 21095547
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Treatment of neuroendocrine tumours of the gastrointestinal tract].
    Hansen CP; Langer S; Frevert S; Mortensen J; Kjaer A; Knigge U
    Ugeskr Laeger; 2010 Oct; 172(43):2942-5. PubMed ID: 21040671
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Morbidity and mortality of aggressive resection in patients with advanced neuroendocrine tumors.
    Norton JA; Kivlen M; Li M; Schneider D; Chuter T; Jensen RT
    Arch Surg; 2003 Aug; 138(8):859-66. PubMed ID: 12912744
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endocrine tumors of the gastrointestinal tract: systemic treatment.
    Oberg K
    Anticancer Drugs; 1994 Oct; 5(5):503-19. PubMed ID: 7858282
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic management of patients with gastroenteropancreatic neuroendocrine tumours.
    Khan MS; Caplin ME
    Endocr Relat Cancer; 2011 Oct; 18 Suppl 1():S53-74. PubMed ID: 22005115
    [TBL] [Abstract][Full Text] [Related]  

  • 10. From targets to treatments: a review of molecular targets in pancreatic neuroendocrine tumors.
    Wiedenmann B; Pavel M; Kos-Kudla B
    Neuroendocrinology; 2011; 94(3):177-90. PubMed ID: 21893937
    [TBL] [Abstract][Full Text] [Related]  

  • 11. State of the art and future prospects in the management of neuroendocrine tumors.
    Oberg K
    Q J Nucl Med; 2000 Mar; 44(1):3-12. PubMed ID: 10932597
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gastroenteropancreatic neuroendocrine tumors: incidence and treatment outcome in a single institution in Korea.
    Lim T; Lee J; Kim JJ; Lee JK; Lee KT; Kim YH; Kim KW; Kim S; Sohn TS; Choi DW; Choi SH; Chun HK; Lee WY; Kim KM; Jang KT; Park YS
    Asia Pac J Clin Oncol; 2011 Sep; 7(3):293-9. PubMed ID: 21884442
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuroendocrine tumors of the gastrointestinal tract: a decade of experience at the Princess Margaret Hospital.
    Rothenstein J; Cleary SP; Pond GR; Dale D; Gallinger S; Moore MJ; Brierley J; Siu LL
    Am J Clin Oncol; 2008 Feb; 31(1):64-70. PubMed ID: 18376230
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Classification and pathology of gastroenteropancreatic neuroendocrine neoplasms.
    Klöppel G
    Endocr Relat Cancer; 2011 Oct; 18 Suppl 1():S1-16. PubMed ID: 22005112
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of somatostatins in gastroenteropancreatic neuroendocrine tumor development and therapy.
    Oberg KE; Reubi JC; Kwekkeboom DJ; Krenning EP
    Gastroenterology; 2010 Sep; 139(3):742-53, 753.e1. PubMed ID: 20637207
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Everolimus in the treatment of renal cell carcinoma and neuroendocrine tumors.
    Chan HY; Grossman AB; Bukowski RM
    Adv Ther; 2010 Aug; 27(8):495-511. PubMed ID: 20623346
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic monitoring of gastroenteropancreatic neuroendocrine tumors: the challenges ahead.
    Sundin A; Rockall A
    Neuroendocrinology; 2012; 96(4):261-71. PubMed ID: 22907438
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Guidelines for the management of gastroenteropancreatic neuroendocrine tumours (including bronchopulmonary and thymic neoplasms). Part I-general overview.
    Oberg K; Astrup L; Eriksson B; Falkmer SE; Falkmer UG; Gustafsen J; Haglund C; Knigge U; Vatn MH; Välimäki M;
    Acta Oncol; 2004; 43(7):617-25. PubMed ID: 15545182
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gastrointestinal neuroendocrine tumors: a role for targeted therapies?
    Kulke MH
    Endocr Relat Cancer; 2007 Jun; 14(2):207-19. PubMed ID: 17639038
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management of neuroendocrine tumors: a meeting of experts from Latin America.
    Costa F; Domenichini E; Garavito G; Medrano R; Mendez G; O'Connor J; Rojas W; Torres S; Younes RN; Delle Fave G; Oberg K
    Neuroendocrinology; 2008; 88(3):235-42. PubMed ID: 18663282
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.